nach oben

CNS Drugs

Erschienen in:

01.02.2002 | Review Article

Depression and Heart Disease

Evidence of a Link, and its Therapeutic Implications

verfasst von: Dr Wei Jiang, Ranga R.K. Krishnan, Christopher M. O’Connor

Erschienen in: CNS Drugs | Ausgabe 2/2002

Einloggen, um Zugang zu erhalten

Abstract

Over several decades, a large body of evidence has emerged to suggest that depressive disorder is a risk factor for heart diseases, both aetiologically and prognostically. Several large, prospective, longitudinal studies have examined the relationship between depression and the development of coronary artery disease (CAD); they reveal that the relationship is significant and independent of conventional risk factors. Prognostic studies have shown that depression is associated with two to three times higher mortality after myocardial infarction, unstable angina or coronary artery bypass grafting, and in patients with stable CAD compared with such patients without depression. Depression also has been found to increase mortality and morbidity in patients with heart failure, regardless of its aetiology. Such adverse associations persist after adjustment for conventional prognostic risk factors.

Despite all of these findings, depressed patients with heart disease are less likely to be recognised clinically as being depressed than those patients who have depression but no heart disease. The very limited evidence available from pharmacological clinical trials raises concern about the safety of antidepressants in CAD and heart failure. In addition, no research has addressed whether the treatment of depression in patients with heart disease will improve their prognosis.

Hallstrom T, Lapidus L, Bengtsson C, et al. Psychosocial factors and risk of ischaemic heart disease and death in women: a twelve-year follow-up of participants in the population study of women in Gothenburg, Sweden. J Psychosom Res 1986; 30: 451–9PubMedCrossRef

Appels A, Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur Heart J 1988 Jul; 9: 758–64PubMedCrossRef

Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993 Jul; 4: 285–94

Aromaa A, Raitasalo R, Reunanen A, et al. Depression and cardiovascular diseases. Acta Psychiatr Scand Suppl 1994; 377: 77–82PubMedCrossRef

Everson SA, Goldberg DE, Kaplan GA, et al. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 1996 Mar; 58: 113–21PubMed

Wassertheil-Smoller S, Applegate WB, Berge K, et al. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the Elderly Project). Arch Intern Med 1996 Mar; 156: 553–61

Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93: 1976–80PubMedCrossRef

Pratt LA, Ford DE, Cram RM, et al. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation 1996; 94: 3123–9PubMedCrossRef

Ford DE, Mead LA, Chang PP, et al. Depression is a risk factor for coronary artery disease in men: the Precursors study. Arch Intern Med 1998 Jul; 158: 1422–6PubMedCrossRef

10.

Mendes de Leon CF, Krumholz HM, Seeman TS, et al. Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982–1991. Established Populations for the Epidemiologic Studies of the Elderly. Arch Intern Med 1998 Nov; 158: 2341–8PubMedCrossRef

11.

Ariyo AA, Haan M, Tangen CM, et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 2000; 102: 1773–9

12.

Ferketich AK, Schwartzbaum JA, Frid DJ, et al. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med 2000; 160: 1261–8

13.

Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001; 58: 221–7PubMedCrossRef

14.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association, 1980

15.

Weeke A, Juel K, Vaeth M. Cardiovascular death and manic-depressive psychosis. J Affect Disord 1987; 13: 287–92PubMedCrossRef

16.

Blazer DG, Kessler RC, McGonagle KA, et al. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994 Jul; 151: 979–86PubMed

17.

Goldberg EL, Comstock GW, Hornstra RK. Depressed mood and subsequent physical illness. Am J Psychiatry 1979 Apr; 136: 530–4PubMed

18.

Vogt T, Pope C, Mullooly J, et al. Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. Am J Public Health 1994 Feb; 84: 227–31PubMedCrossRef

19.

Kubzansky LD, Kawachi I, Spiro AI, et al. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the normative aging study. Circulation 1997; 95: 818–24PubMedCrossRef

20.

Wetzel RD, Margulies T, Davis R, et al. Hopelessness, depression, and suicide intent. J Clin Psychiatry 1980 May; 41: 159–60PubMed

21.

Beck AT, Steer RA, Kovacs M, et al. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 1985 May; 142: 559–63PubMed

22.

Kaufman DW, Helmrich SP, Rosenberg L, et al. Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N Engl J Med 1983 Feb; 308: 409–13PubMedCrossRef

23.

Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989 Jan–Feb; 9(1 Suppl.): 119–32

24.

Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997 Apr; 154: 497–501PubMed

25.

Doraiswamy PM, MacFall J, Krishnan KR, et al. Magnetic resonance assessment of cerebral perfusion in depressed cardiac patients: preliminary findings. Am J Psychiatry 1999 Oct; 156: 1641–3PubMed

26.

Stern MJ, Pascale L, Ackerman A. Life adjustment postmyo-cardial infarction: determining predictive variables. Arch Intern Med 1977 Dec; 137: 1680–5PubMedCrossRef

27.

Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149: 1785–9PubMedCrossRef

28.

Ahern DK, Gorkin L, Anderson JL, et al. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990; 66: 59–62PubMedCrossRef

29.

Ladwig KH, Roll G, Breithardt G, et al. Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 1994 Jan; 343: 20–3PubMedCrossRef

30.

Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270(15): 1819–25PubMedCrossRef

31.

Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999–1005PubMedCrossRef

32.

Denollet J, Brutsaert DL. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 1998 Jan; 97: 167–73PubMedCrossRef

33.

Frasure-Smith N, Lesperance F, Juneau M, et al. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 1999 Jan; 61: 26–37PubMed

34.

Irvine J, Basinski A, Baker B, et al. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med 1999; 61: 729–37PubMed

35.

Lane D, Carroll D, Ring C, et al. Mortality and quality of life after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001; 63: 221–30PubMed

36.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994

37.

Forrester AW, Lipsey JR, Teitelbaum ML, et al. Depression following myocardial infarction. Int J Psychiatry Med 1992; 22: 33–46PubMedCrossRef

38.

Shapiro PA, Lesperance F, Frasure-Smith N, et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Am Heart J 1999; 137: 1100–6PubMedCrossRef

39.

Mayou RA, Gill D, Thompson DR, et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000; 62: 212–9PubMed

40.

Ladwig KH, Roll G, Breithardt G, et al. Extracardiac contributions to chest pain perception in patients 6 months after acute myocardial infarction. Am Heart J 1999 Mar; 137: 528–35PubMedCrossRef

41.

Carney RM, Freedland KE, Eisen SA, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995 Jan; 14: 88–90PubMedCrossRef

42.

Hance M, Carney RM, Freedland KE, et al. Depression in patients with coronary heart disease: a 12-month follow-up. Gen Hosp Psychiatry 1996 Jan; 18: 61–5PubMedCrossRef

43.

Gonzalez MB, Snyderman TB, Colket JT, et al. Depression in patients with coronary artery disease. Depression 1996; 4: 57–62PubMedCrossRef

44.

Sullivan M, LaCroix A, Russo J, et al. Depression in coronary heart disease. What is the appropriate diagnostic threshold? Psychosomatics 1999 Jul; 40(4): 286–92

45.

Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988 Nov; 50: 627–33PubMed

46.

Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78: 613–7PubMedCrossRef

47.

Jiang W, Hathaway WR, McNulty S, et al. Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol 1997 Sep; 80: 808–11PubMedCrossRef

48.

Gullette ECD, Blumenthal JA, Babyak M, et al. Effects of mental stress on myocardial ischemia during daily life. JAMA 1997; 277: 1521–6PubMedCrossRef

49.

Lesperance F, Frasure-Smith N, Juneau M, et al. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000; 160: 1354–60PubMedCrossRef

50.

Saur CD, Granger BB, Muhlbaier LH, et al. Depressive symptoms and outcome of coronary artery bypass grafting. Am J Crit Care 2001; 10: 4–10PubMed

51.

Baker RA, Andrew MJ, Schrader G, et al. Preoperative depression and mortality in coronary artery bypass surgery: preliminary findings. A NZ J Surg 2001; 71(3): 139–42CrossRef

52.

Konstam MA, Dracup K, Baker D, et al. Heart failure: evaluation and care of patients with left-ventricular dysfunction. Clin Pract Guidel Quick Ref Guide Clin 1994; (11): 1–21

53.

Gooding J, Jette AM. Hospital readmissions among the elderly. J Am Geriatr Soc 1985 Sep; 33: 595–601PubMed

54.

Rich MW, Freedland KE. Effect of DRGs on three-month read- mission rate of geriatric patients with congestive heart failure. Am J Public Health 1988 Jun; 78: 680–2PubMedCrossRef

55.

Vinson JM, Rich MW, Sperry JC, et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990; 38: 1290–5PubMed

56.

Krumholz HM, Butler J, Miller J, et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998; 97: 958–64PubMedCrossRef

57.

Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 1998 Jan; 20: 29–43PubMedCrossRef

58.

Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001 Aug; 161: 1849–56PubMedCrossRef

59.

Murberg TA, Bru E, Svebak S, et al. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-years follow-up study. Int J Psychiatry Med 1999; 29: 311–26PubMedCrossRef

60.

Vaccarino V, Kasl SV, Abramson J, et al. Depression symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001; 38: 199–205PubMedCrossRef

61.

Mayo-Smith W, Hayes CW, Biller BM, et al. Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology 1989 Feb; 170: 515–8PubMed

62.

Thakore JH, Richards PJ, Reznek RH, et al. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry 1997 Jun; 41: 1140–2PubMedCrossRef

63.

Veith RC, Lewis N, Linares OA, et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1994 May; 51: 411–22

64.

Krittayaphong R, Cascio WE, Light KC, et al. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med 1997 May; 59: 231–5PubMed

65.

Watkins LL, Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J 1999 Mar; 137: 453–7PubMedCrossRef

66.

Carney RM, Saunders RD, Freedland KE, et al. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995 Sep; 76: 562–4PubMedCrossRef

67.

Hughes JW, Stoney CM. Depressed mood is related to high-frequency heart rate variability during Stressors. Psychosom Med 2000; 62: 796–803PubMed

68.

Pitzalis MV, Iacoviello M, Todarello O, et al. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. Am Heart J 2001; 141: 765–71PubMedCrossRef

69.

Kleiger RE, Miller JP, Bigger Jr JT, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256–62PubMedCrossRef

70.

Patrono C, Renda G. Platelet activation and inhibition in unstable coronary syndromes. Am J Cardiol 1997 Sep; 80(5A): 17E–20EPubMedCrossRef

71.

Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996 Oct; 153: 1313–7PubMed

72.

Reichborn-Kjennerud T, Lingjaerde O, Oreland L. Platelet monoamine oxidase activity in patients with winter seasonal affective disorder. Psychiatry Res 1996 Jun; 62: 273–80PubMedCrossRef

73.

Laghrissi-Thode F, Wagner WR, Pollock BG, et al. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997 Aug; 42: 290–5PubMedCrossRef

74.

Appels A, Bar FW, Bar J, et al. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 2000; 62: 601–5PubMed

75.

Siegler HC, Blumenthal JA, Barefoot JC, et al. Personality factors differentially predict exercise behavior in men and women. Womens Health 1997; 3: 61–70PubMed

76.

Adler NE, Boyce T, Chesney MA, et al. Socioeconomic status and health: the challenge of the gradient. Am Psychol 1994 Jan; 49: 15–24PubMedCrossRef

77.

Berkman LF. The role of social relations in health promotion. Psychosom Med 1995 May; 57: 245–54PubMed

78.

Williams RB, Barefoot JC, Califf RM, et al. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA 1992; 267: 520–4PubMedCrossRef

79.

Horsten M, Mittleman MA, Wamala SP, et al. Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study. Eur Heart J 2000 Jul; 21: 1072–80

80.

Blumenthal JA, Williams RS, Wallace AG, et al. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med 1982; 44: 519–27PubMed

81.

Ziegelstein RC, Fauerbach JA, Stevens SS, et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000 Jun; 160: 1818–23PubMedCrossRef

82.

Krishnan KR, George LK, Pieper CF, et al. Depression and social support in elderly patients with cardiac disease. Am Heart J 1998 Sep; 136: 491–5PubMedCrossRef

83.

Strik JJMH, Honig A, Lousberg R, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000; 62: 783–9PubMed

84.

Veith RC, Raskind MA, Caldwell JH, et al. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med 1982 Apr; 306: 954–9PubMedCrossRef

85.

Nelson JC, Kennedy JS, Pollock BG, et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry 1999 Jul; 156: 1024–8PubMed

86.

Roose SP, Glassman AH, Giardina EG, et al. Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. J Clin Psychopharmacol 1987 Aug; 7: 247–51PubMedCrossRef

87.

Raisfeld IH. Cardiovascular complications of antidepressant therapy: interactions at the adrenergic neuron. Am Heart J 1972 Jan; 83: 129–33PubMedCrossRef

88.

Baker B, Dorian P, Sandor P, et al. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. J Clin Psychopharmacol 1997 Feb; 17: 15–21PubMedCrossRef

89.

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 1989; 321: 406-12

90.

Upward JW, Edwards JG, Goldie A, et al. Comparative effects of fluoxetine and amitriptyline on cardiac function. Br J Clin Pharmacol 1988 Oct; 26: 399–402PubMedCrossRef

91.

Roose SP, Dalack GW, Glassman AH, et al. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 1991 Apr; 148: 512–6PubMed

92.

Laird LK, Lydiard RB, Morton WA, et al. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients. J Clin Psychiatry 1993 Jun; 54: 224–8PubMed

93.

Kiev A, Masco HL, Wenger TL, et al. The cardiovascular effects of bupropion and nortriptyline in depressed outpatients. Ann Clin Psychiatry 1994 Jun; 6: 107–15PubMedCrossRef

94.

Hewer W, Rost W, Gattaz WF. Cardiovascular effects of fluvoxamine and maprotiline in depressed patients. Eur Arch Psychiatry Clin Neurosci 1995; 246: 1–6PubMedCrossRef

95.

Tulen JH, Bruijn JA, de Man KJ, et al. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). J Clin Psychopharmacol 1996 Apr; 16: 135–45PubMedCrossRef

96.

Feighner JP. Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry 1995 Dec; 56: 574–9PubMed

97.

Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 1998 Oct; 59: 502–8PubMedCrossRef

98.

van de Merwe TJ, Silverstone T, Ankier SI, et al. A double-blind non-crossover placebo-controlled study between group comparison of trazodone and amitriptyline on cardiovascular function in major depressive disorder. Psychopathology 1984; 17Suppl. 2: 64–76PubMedCrossRef

99.

Janowsky D, Curtis G, Zisook S, et al. Trazodone-aggravated ventricular arrhythmias. J Clin Psychopharmacol 1983; 3: 372–6PubMedCrossRef

100.

Avery D, Winokur G. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 1976 Sep; 33: 1029–37PubMedCrossRef

101.

Enhancing recovery in coronary heart disease patients (EN-RICHD): study design and methods. The ENRICHD Investigators. Am Heart J 2001 Jan; 139: 1-9

102.

Alvarez JC, Gluck N, Arnulf I, et al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clin Pharmacol Ther 1999 Dec; 66: 617–24PubMed

103.

Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol 2000 Apr; 20: 137–40PubMedCrossRef

104.

Markovitz JH, Shuster JL, Chitwood WS, et al. Platelet activation in depression and effects of sertraline treatment: an open-label study. Am J Psychiatry 2000 Jun; 157: 1006–8PubMedCrossRef

105.

Musselman DL, Marzec UM, Manatunga A, et al. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 2000 Sep; 57: 875–82PubMedCrossRef

106.

Rechlin T, Weis M, Claus D. Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions. Pharmacopsychiatry 1994 May; 27: 124–8PubMedCrossRef

107.

Khaykin Y, Dorian P, Baker B, et al. Autonomie correlates of antidepressant treatment using heart-rate variability analysis. Can J Psychiatry 1998 Mar; 43: 183-6PubMed

Titel: Depression and Heart Disease
Evidence of a Link, and its Therapeutic Implications
verfasst von: Dr Wei Jiang
Ranga R.K. Krishnan
Christopher M. O’Connor
Publikationsdatum: 01.02.2002
Verlag: Springer International Publishing
Erschienen in: CNS Drugs / Ausgabe 2/2002
Print ISSN: 1172-7047
Elektronische ISSN: 1179-1934
DOI: https://doi.org/10.2165/00023210-200216020-00004

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Depression and Heart Disease

Evidence of a Link, and its Therapeutic Implications

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2002

Is Attention Deficit Hyperactivity Disorder Increasing Among Girls in the US?

Prescribing of Psychotropics in the Elderly

Atypical Antipsychotic-Induced Diabetes Mellitus

Spotlight on Fluvoxamine in Anxiety Disorders in Children and Adolescents

Scizures in HIV-Seropositive Individuals

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie